TIRAP — TIR Domain-Containing Adaptor Protein

TIRAP — TIR Domain-Containing Adaptor Protein

Overview

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">TIRAP — TIR Domain-Containing Adaptor Protein</th>
</tr>
<tr>
<td class="label">Cell Type</td>
<td>Expression Level</td>
</tr>
<tr>
<td class="label">Microglia</td>
<td>High</td>
</tr>
<tr>
<td class="label">Astrocytes</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Neurons</td>
<td>Low-Moderate</td>
</tr>
<tr>
<td class="label">Oligodendrocytes</td>
<td>Low</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/inflammation" style="color:#ef9a9a">Inflammation</a>, <a href="/wiki/ms" style="color:#ef9a9a">Ms</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">20 edges</a></td>
</tr>
</table>

TIRAP — TIR Domain-Containing Adaptor Protein

Overview

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">TIRAP — TIR Domain-Containing Adaptor Protein</th>
</tr>
<tr>
<td class="label">Cell Type</td>
<td>Expression Level</td>
</tr>
<tr>
<td class="label">Microglia</td>
<td>High</td>
</tr>
<tr>
<td class="label">Astrocytes</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Neurons</td>
<td>Low-Moderate</td>
</tr>
<tr>
<td class="label">Oligodendrocytes</td>
<td>Low</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/inflammation" style="color:#ef9a9a">Inflammation</a>, <a href="/wiki/ms" style="color:#ef9a9a">Ms</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">20 edges</a></td>
</tr>
</table>

TIRAP (TIR Domain-Containing Adaptor Protein) is a critical signaling adaptor protein that mediates Toll-like receptor (TLR) signaling in the innate immune system. Originally identified as an essential adaptor for TLR4-mediated responses to lipopolysaccharide (LPS), TIRAP plays a pivotal role in bridging pattern recognition receptors to downstream inflammatory signaling cascades[@takeda2003][@o'Neill2003]. In the central nervous system, TIRAP is expressed in [microglia](/cell-types/microglia), [astrocytes](/cell-types/astrocytes), and [neurons](/cell-types/neurons), where it contributes to neuroinflammatory processes implicated in neurodegenerative diseases including [Alzheimer's disease](/diseases/alzheimers-disease), [Parkinson's disease](/diseases/parkinsons-disease), and [amyotrophic lateral sclerosis](/diseases/amyotrophic-lateral-sclerosis)[@piccinini2020][@menshchikova2022][@liu2023].

The TIRAP gene is located on chromosome 11p15.5 and encodes a 235-amino acid protein characterized by a TIR domain at its C-terminus, which is essential for protein-protein interactions with other TIR domain-containing proteins including TLRs and downstream signaling molecules[@takeda2003]. The protein functions as a molecular scaffold, bringing signaling components into proximity with activated TLRs to facilitate signal transduction.

Genomic Architecture

The TIRAP gene (Ensembl: ENSG00000150459, NCBI Gene ID: 114609) spans approximately 4.5 kb of genomic DNA and consists of 6 exons. The gene encodes a protein of 235 amino acids with a molecular weight of approximately 28 kDa. Key structural features include:

• N-terminal domain: Contains a phosphatidylinositol 4,5-bisphosphate (PIP2)-binding motif that enables membrane localization
• TIR domain: The C-terminal TIR domain (approximately 170 amino acids) mediates homotypic interactions with other TIR domain-containing proteins
• Death domain: A central death domain-like region involved in apoptotic signaling

TIRAP in Innate Immunity

TLR Signaling Pathway

TIRAP serves as a critical adaptor protein in multiple Toll-like receptor signaling pathways. The TLR family recognizes pathogen-associated molecular patterns (PAMPs) and damage-associated molecular patterns (DAMPs), initiating innate immune responses[@takeda2003]. TIRAP is essential for signaling through:

• TLR4: The receptor for lipopolysaccharide (LPS) from Gram-negative bacteria, the most extensively studied TIRAP-dependent pathway[@o'Neill2003]
• TLR2: Recognizes lipoproteins and peptidoglycan from Gram-positive bacteria
• TLR3, TLR7, TLR8: Recognize viral nucleic acids (double-stranded RNA and single-stranded RNA)

Signal Transduction Cascade

The pathway proceeds through interleukin-1 receptor-associated kinase (IRAK) family members, leading to activation of transforming growth factor beta-activated kinase 1 (TAK1), which subsequently activates both the IKK complex (leading to NF-kappaB activation) and MAPK cascades (leading to AP-1 activation)[@o'Neill2003]. This results in the transcription of numerous pro-inflammatory mediators including TNF-alpha, IL-1beta, IL-6, and chemokines.

TIRAP in Neurodegeneration

Alzheimer's Disease

In Alzheimer's disease, chronic neuroinflammation driven by innate immune activation is a key pathological feature[@heneka2015]. TIRAP-mediated TLR signaling contributes to this process through multiple mechanisms:

Microglial Activation: TIRAP expression in microglia is upregulated in response to amyloid-beta (Aβ) plaques. The TLR4/TIRAP/MyD88 pathway drives microglial production of pro-inflammatory cytokines (TNF-α, IL-1β, IL-6) that contribute to synaptic dysfunction and neuronal loss[@menshchikova2022]. Amyloid-beta can directly activate TLR4, creating a feed-forward neuroinflammatory loop mediated in part by TIRAP signaling.

Tau Pathology: Emerging evidence suggests that TLR signaling may influence tau phosphorylation and spread. TIRAP-dependent signaling can modulate kinases involved in tau pathology, potentially linking neuroinflammation to protein aggregation[@goldberg2021].

Therapeutic Implications: Targeting TIRAP or its downstream signaling partners represents a potential therapeutic approach for AD. Small molecule inhibitors of TLR signaling have shown promise in preclinical models, though selective TIRAP targeting remains challenging[@czirr2015].

Parkinson's Disease

In Parkinson's disease, neuroinflammation centered on activated microglia is a hallmark finding[@liu2023]. TIRAP plays a central role in microglial responses to:

α-Synuclein: Aggregated alpha-synuclein (the protein that forms Lewy bodies in PD) can activate microglia through TLR2 and TLR4, with TIRAP serving as the essential adaptor. This leads to production of nitric oxide (NO), reactive oxygen species (ROS), and pro-inflammatory cytokines that contribute to dopaminergic neuron loss[@liu2023].

Mitochondrial DAMPs: Mitochondrial dysfunction releases damage-associated molecular patterns (mitochondrial DNA, N-formyl peptides) that activate TLR9 and TLR4 pathways, with TIRAP mediating the inflammatory response.

Leucine-Rich Repeat Kinase 2 (LRRK2): Common PD-associated mutations in LRK2 (G2019S) enhance microglial TIRAP signaling, potentially explaining the heightened inflammatory responses observed in LRRK2-associated PD[@liu2023].

Amyotrophic Lateral Sclerosis

In ALS, TIRAP-mediated neuroinflammation contributes to motor neuron degeneration. Activated microglia expressing high levels of TIRAP and other TLR signaling components are found surrounding motor neurons in ALS patient tissue and mouse models. The inflammatory milieu, mediated in part by TIRAP-dependent pathways, accelerates motor neuron death.

Expression Pattern in the Brain

TIRAP is expressed in multiple brain regions and cell types:

In the healthy brain, TIRAP expression is relatively low but detectable. Upon immune challenge or neurodegeneration, TIRAP expression increases significantly in activated glia.

TIRAP Polymorphisms and Disease Risk

Genetic variations in TIRAP have been studied for associations with infectious diseases and inflammatory conditions. The S180L polymorphism (rs8177374) has been associated with altered TLR signaling and susceptibility to:

• Infectious diseases (malaria, tuberculosis)
• Inflammatory disorders (rheumatoid arthritis)
• Some studies suggest potential associations with Alzheimer's disease risk, though results have been inconsistent

Therapeutic Targeting

TIRAP represents a potential therapeutic target for neurodegenerative diseases characterized by neuroinflammation. Approaches under investigation include:

See Also

• [Toll-Like Receptor Signaling](/mechanisms/tlr-signaling-pathway)
• [Neuroinflammation in Alzheimer's Disease](/mechanisms/ad-neuroinflammation-microglia-pathway)
• [Microglia in Parkinson's Disease](/cell-types/microglia-parkinson-disease)
• [Neuroinflammation Mechanisms](/mechanisms/neuroinflammation-microglia)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Amyotrophic Lateral Sclerosis](/diseases/amyotrophic-lateral-sclerosis)

External Links

• [TIRAP Gene - NCBI Gene](https://www.ncbi.nlm.nih.gov/gene/114609)
• [Ensembl: TIRAP](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000150459)
• [UniProt: TIRAP](https://www.uniprot.org/uniprot/Q7L0P6)
• [GeneCards: TIRAP](https://www.genecards.org/cgi-bin/carddisp.pl?gene=TIRAP)

References

Pathway Diagram

The following diagram shows the key molecular relationships involving TIRAP — TIR Domain-Containing Adaptor Protein discovered through SciDEX knowledge graph analysis: